ocular hypertension การใช้

• A 13-oxaprostaglandin analogue has been shown to treat glaucoma and ocular hypertension.
• "Clearly, the case for selective treatment of ocular hypertension has been strengthened, " he said.
• It has been shown that the first symptoms of this disease are usually ocular hypertension.
• "' Unoprostone "'( open-angle glaucoma and ocular hypertension, but is now discontinued in the US.
• Ocular hypertension is treated with either medications or laser.
• When discussing other forms of hypertension, the type of hypertension is included, such as ocular hypertension.
• In some cases, abnormally high pressure inside the eyeball ( ocular hypertension ) can also result.
• The study involved 1, 636 Americans aged 40 to 80 with ocular hypertension but no signs of glaucoma.
• LINGO1 binds with TrkB inhibiting the activation of TkrB by binding of BNDF after the induction of ocular hypertension.
• Fardi Medicals ) is a carbonic anhydrase inhibitor used to lower intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
• In this study 27 patients that had glaucoma or ocular hypertension were given l-moprolol eye drops twice a day for 4 weeks.
• "' Travoprost "'ophthalmic solution is a topical medication used for controlling the progression of glaucoma or ocular hypertension, by reducing intraocular pressure.
• Older people, people of African descent and those with a family history of glaucoma who also have ocular hypertension most commonly develop the disease.
• Ocular hypertension ( OHT ) is defined by intraocular pressure being higher than normal, in the absence of optic nerve damage or visual field loss.
• It is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension and who are insufficiently responsive to beta-blockers.
• Beardsley agreed with the researchers'conclusions that people with asthma who use inhaled steroids for extended periods should be screened regularly for glaucoma and ocular hypertension.
• Ocular hypertension, often a precursor to glaucoma, is a condition marked by increased pressure within the eye that can result in partial or total vision loss.
• An increased corneal thickness is correlated to individuals with ocular hypertension, whereas a decreased corneal thickness has been identified in individuals with IOP within normal limits.
• The Ocular Hypertension Treatment Study, a large, multicentered, randomized clinical trial, determined that topical ocular hypotensive medication delays or prevents the onset of Primary Open-Angle Glaucoma.
• Better than BDNF and BII003 ( LINGO1 antagonist ) alone, the combined treatment of both provides long term RCG neuroprotection after the induction of ocular hypertension.